Evidence map›Paper›PMID 42001368›Full record

ArticleActa neuropathologica2026

Primitive neuronal component is a frequent finding among IDH-mutant astrocytomas with RB1 alterations.

Cheyanne C Slocum, Jamal K Benhamida, Scott Eckert, Erika Gedvilaite, Ryan Ptashkin, Viviane Tabar, Robert J Young, Marc Ladanyi, Ingo K Mellinghoff, Marc K Rosenblum and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cheyanne C SlocumDeparment of Pathology, New York Presbyterian Hospital, NY, New York, USA.
Jamal K BenhamidaDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Scott EckertDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Erika GedvilaiteDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Ryan PtashkinDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Viviane TabarDeparment of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Robert J YoungDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marc LadanyiDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Ingo K MellinghoffDepartment of Neuro-Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marc K RosenblumDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
A Rose BrannonDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Richard HickmanDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Tejus A BaleDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. balet@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS Cancer Center Core Grant No. P30-CA008748NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42001368
PMCPMC13092521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.